Read more

February 08, 2022
2 min read
Save

Cataract surgery may improve visual acuity in patients with AMD

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Cataract surgery improved visual acuity for patients with intermediate age-related macular degeneration and neovascular AMD, according to a study published in the Canadian Journal of Ophthalmology.

Perspective from Chad Killen, OD, FAAO

“In summary, we found that patients with [geographic atrophy] do not experience significant visual acuity gain with cataract surgery, whereas those with iAMD [intermediate AMD] and nAMD [neovascular AMD] do,” Andrew X. Chen, BSE, of Case Western Reserve University School of Medicine and the Center for Ophthalmic Bioinformatics in Cleveland, and colleagues wrote. “Control groups each exhibited significantly higher postoperative VA [visual acuity] and larger improvements in VA compared with their respective AMD groups. In all AMD groups, preoperative VA was a strong predictor of visual outcomes, and individuals with the worst preoperative vision gained the most letters.”

Chen and colleagues designed a retrospective cohort study to evaluate postoperative VA outcomes in AMD patients who underwent cataract surgery. They compared AMD patients with healthy control participants, all of whom underwent cataract surgery between 2012 and 2017.

The researchers categorized the eyes into three AMD groups: iAMD (216 patients), fovea-involving geographic atrophy (GA; 35 patients) and nAMD (184 patients). These groups were compared with three preoperative VA-matched control groups: iAMDc (130 ), fovea-involving GA control (GAc; 31) and neovascular AMD control (nAMDc; 129). The researchers used multiple linear regression models to evaluate changes in VA at 12 months.

According to the study, 12-month postoperative VA increased significantly in the iAMD (+10.1 ± 14.5 letters) and nAMD (+9.7 ± 18.9 letters) groups. In addition, each control group showed significant VA gains (iAMDc: +17.1 ± 9.7; GAc: +30 ± 12.9; and nAMDc: +26.4 ± 15.6 letters, P < .001 for all). For AMD groups, VA and gain in VA were lower than in the control groups 12 months postoperatively (P < .01), with better preoperative VA predicting smaller VA gains (P .007), while poorer VA outcomes were linked with longer duration of AMD in patients with iAMD, ellipsoid zone disruption in nAMD and lower central subfield thickness in GA (P < .05).

These findings support previous research on VA improvements from cataract surgery in patients with iAMD and nAMD and also suggest that cataract surgery can modify aspects of visual function such as glare, contrast sensitivity, color vision and peripheral vision in fovea-involving GA.

“Cataract surgery improves VA for patients with iAMD and nAMD, albeit not to the level of those without retinal pathology,” Chen and colleagues wrote. “Preoperative VA, AMD duration and OCT parameters may be important prognostic factors for cataract surgery in patients with AMD.”